We are live on ! Find out more
CA

Calton & Associates Portfolio holdings

AUM $683M
1-Year Est. Return 28.95%
This Fund
S&P 500
This Quarter Est. Return
+8.11%
1 Year Est. Return
+28.95%
3 Year Est. Return
+73.86%
5 Year Est. Return
+79.5%
10 Year Est. Return
AUM
$375M
AUM Growth
-$82M
Cap. Flow
-$110M
Cap. Flow %
-29.45%
Top 10 Hldgs %
22.11%
Holding
418
New
23
Increased
131
Reduced
197
Closed
53

Sector Composition

Rank Sector Weight
1 Technology 10.12%
2 Financials 3.31%
3 Consumer Discretionary 3.24%
4 Healthcare 3.2%
5 Industrials 2.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRVL icon
276
Marvell Technology
MRVL
$188B
$281K 0.08%
+3,218
New +$240K
XLU icon
277
State Street Utilities Select Sector SPDR ETF
XLU
$22.6B
$281K 0.08%
7,862
+550
+8% +$18.6K
OKE icon
278
Oneok
OKE
$57.6B
$280K 0.07%
4,773
+28
+0.6% +$1.74K
NI icon
279
NiSource
NI
$20B
$279K 0.07%
10,108
+98
+1% +$2.49K
C icon
280
Citigroup
C
$229B
$277K 0.07%
4,592
-893
-16% -$59.4K
GNR icon
281
State Street SPDR S&P Global Natural Resources ETF
GNR
$4.94B
$277K 0.07%
5,142
+248
+5% +$13.3K
DON icon
282
WisdomTree US MidCap Dividend Fund
DON
$4.09B
$273K 0.07%
6,166
+21
+0.3% +$916
CAT icon
283
Caterpillar
CAT
$389B
$272K 0.07%
1,318
-110
-8% -$22.1K
LKQ icon
284
LKQ Corp
LKQ
$6.26B
$272K 0.07%
4,540
-78
-2% -$4.4K
RJF icon
285
Raymond James Financial
RJF
$34.7B
$272K 0.07%
2,715
RDVY icon
286
First Trust Rising Dividend Achievers ETF
RDVY
$25.6B
$269K 0.07%
5,203
+595
+13% +$30K
MDT icon
287
Medtronic
MDT
$115B
$268K 0.07%
2,598
-1,515
-37% -$175K
VST icon
288
Vistra
VST
$48.5B
$268K 0.07%
11,787
+208
+2% +$4.17K
ASML icon
289
ASML
ASML
$686B
$266K 0.07%
334
+20
+6% +$15.9K
DTE icon
290
DTE Energy
DTE
$28.5B
$266K 0.07%
2,230
-133
-6% -$15.2K
NRG icon
291
NRG Energy
NRG
$25.3B
$265K 0.07%
6,152
+43
+0.7% +$1.69K
AXIA
292
DELISTED
AXIA Energia
AXIA
$264K 0.07%
54,844
+233
+0.4% +$1.17K
TSCO icon
293
Tractor Supply
TSCO
$18.7B
$262K 0.07%
5,490
-105
-2% -$4.59K
EUFN icon
294
iShares MSCI Europe Financials ETF
EUFN
$4.27B
$261K 0.07%
13,055
+25
+0.2% +$507
TCHP icon
295
T. Rowe Price Blue Chip Growth ETF
TCHP
$2.19B
$261K 0.07%
7,901
+849
+12% +$28.3K
VRTX icon
296
Vertex Pharmaceuticals
VRTX
$134B
$260K 0.07%
1,188
+13
+1% +$2.53K
SBUX icon
297
Starbucks
SBUX
$121B
$259K 0.07%
2,216
-191
-8% -$21.5K
BMY icon
298
Bristol-Myers Squibb
BMY
$130B
$258K 0.07%
4,145
-1,882
-31% -$110K
BIO icon
299
Bio-Rad Laboratories Class A
BIO
$9.48B
$255K 0.07%
338
-7
-2% -$5.24K
TAXF icon
300
American Century Diversified Municipal Bond ETF
TAXF
$686M
$253K 0.07%
4,584

Similar funds

Calton & Associates's Q4 2021 Portfolio in Review

As of Q4 2021, Calton & Associates held 418 positions worth $375M, down 18% from $457M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Calton & Associates withdrew a net $110M in Q4 2021, closing 53 positions and reducing 197 holdings. Its most notable exit was iShares iBonds Dec 2021 Term Corporate ETF, an estimated $4.88M position sold in full.

By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 7.8% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Calton & Associates opened a new position in Invesco S&P MidCap Low Volatility ETF worth $2.88M.

  • Calton & Associates's largest Q4 2021 buy was Invesco S&P MidCap Low Volatility ETF: 49,228 shares worth $2.88M.
  • Calton & Associates added most to iShares TIPS Bond ETF in Q4 2021, an estimated $2.16M increase.
  • Calton & Associates's biggest Q4 2021 reduction was iShares Core S&P Total US Stock Market ETF, cutting an estimated $17.9M.
  • Calton & Associates fully exited iShares iBonds Dec 2021 Term Corporate ETF in Q4 2021, selling an estimated $4.88M.
  • Calton & Associates's ten largest holdings make up 22% of its $375M portfolio in Q4 2021.
  • Calton & Associates opened 23 new positions and closed 53 in Q4 2021.
  • Calton & Associates's portfolio value fell 18% quarter-over-quarter to $375M.

Based on Calton & Associates's 13F filing for Q4 2021, filed 13 Jan 2022.